The roles of CD73 in cancer (Q34003164)

30 July 2017

2 references

7 April 2021

13 January 2024

The roles of CD73 in cancer (English)

1 reference

30 July 2017

1 reference

19 June 2019

1 reference

28 September 2019

1 reference

1 December 2020

1 reference

7 April 2021

Zhao-wei Gao

1 reference

30 July 2017

Ke Dong

series ordinal

1 reference

30 July 2017

Hui-zhong Zhang

series ordinal

1 reference

30 July 2017

language of work or name

English

0 references

publication date

14 July 2014

9 references

BioMed Research International

30 July 2017

3 April 2019

19 June 2019

30 June 2019

28 September 2019

18 September 2020

1 December 2020

7 April 2021

13 January 2024

8 references

30 July 2017

3 April 2019

19 June 2019

30 June 2019

28 September 2019

1 December 2020

7 April 2021

13 January 2024

2014

1 reference

30 July 2017

page(s)

460654

1 reference

Creative Commons Attribution 3.0 Unported

30 July 2017

7 references

3 April 2019

19 June 2019

30 June 2019

28 September 2019

1 December 2020

7 April 2021

on focus list of Wikimedia project

13 January 2024

copyrighted

0 references

ScienceSource

0 references

cites work

Adenosine limits the therapeutic effectiveness of anti-CTLA4 mAb in a mouse melanoma model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

NT5E and FcGBP as key regulators of TGF-1-induced epithelial-mesenchymal transition (EMT) are associated with tumor progression and survival of patients with gallbladder cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Inhibition of CD73 stimulates the migration and invasion of B16F10 melanoma cells in vitro, but results in impaired angiogenesis and reduced melanoma growth in vivo

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Purinergic signalling and cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

CD39 and CD73 in immunity and inflammation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Expression and clinical significance of CD73 and hypoxia-inducible factor-1α in gastric carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Ecto-5'-nucleotidase (CD73) promotes tumor angiogenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Mechanisms of resistance to anti-angiogenesis therapies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

The adenosinergic system in cancer: Key therapeutic target

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Adenosine induces cell cycle arrest and apoptosis via cyclinD1/Cdk4 and Bcl-2/Bax pathways in human ovarian cancer cell line OVCAR-3.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Dual, enzymatic and non-enzymatic, function of ecto-5'-nucleotidase (eN, CD73) in migration and invasion of A375 melanoma cells.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Production of adenosine by ectonucleotidases: a key factor in tumor immunoescape

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Overexpression of CD73 in epithelial ovarian carcinoma is associated with better prognosis, lower stage, better differentiation and lower regulatory T cell infiltration

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Characterization of ectonucleotidases in human medulloblastoma cell lines: ecto-5'NT/CD73 in metastasis as potential prognostic factor

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Enzyme-coupled assays for simultaneous detection of nanomolar ATP, ADP, AMP, adenosine, inosine and pyrophosphate concentrations in extracellular fluids.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

5'-ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

The double-edge sword effect of anti-CD73 cancer therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

CD73 promotes tumor growth and metastasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

NT5E CpG island methylation is a favourable breast cancer biomarker

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

CD73: a potent suppressor of antitumor immune responses

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

The blockade of immune checkpoints in cancer immunotherapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

CD73-deficient mice are resistant to carcinogenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Alterations in the extracellular catabolism of nucleotides are involved in the antiproliferative effect of quercetin in human bladder cancer T24 cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

FK506 confers chemosensitivity to anticancer drugs in glioblastoma multiforme cells by decreasing the expression of the multiple resistance-associated protein-1.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Hallmarks of Cancer: The Next Generation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

RNAi-mediated CD73 suppression induces apoptosis and cell-cycle arrest in human breast cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Hypoxia-inducible factor 1: Regulator of mitochondrial metabolism and mediator of ischemic preconditioning

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Extracellular adenosine triphosphate and adenosine in cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Differential ectonucleotidase expression in human bladder cancer cell lines

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

The role of ecto-5'-nucleotidase/CD73 in glioma cell line proliferation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Adenosine receptors in regulation of dendritic cell differentiation and function

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

RNA interference of ecto-5'-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Effects of ecto-5'-nucleotidase on human breast cancer cell growth in vitro and in vivo.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Growth inhibitory effect and apoptosis induced by extracellular ATP and adenosine on human gastric carcinoma cells: involvement of intracellular uptake of adenosine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Gs protein-coupled adenosine receptor signaling and lytic function of activated NK cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Thyroid hormone stimulates 5'-ecto-nucleotidase of neonatal rat ventricular myocytes.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Wnt and beta-catenin signaling target the expression of ecto-5'-nucleotidase and increase extracellular adenosine generation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5'-nucleotidase) up-regulation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Evidence for the involvement of ecto-5'-nucleotidase (CD73) in drug resistance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Purinergic signalling and diabetes

5 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F460654

High expression of CD73 as a poor prognostic biomarker in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F460654

CD73 (5'-nucleotidase) expression has no prognostic value in children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F460654

Overexpression of CD73 in prostate cancer is associated with lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F460654

Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F460654

Altered purinergic signaling in CD73-deficient mice inhibits tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F460654

Overexpression of Ecto-5'-Nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F460654

Anti-CD73 therapy impairs tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F460654

Lack of ecto-5'-nucleotidase (CD73) promotes arteriogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F460654

Thyroid hormone upregulates ecto-5'-nucleotidase/CD73 in C6 rat glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F460654

Effect of hypoxia/reoxygenation on CD73 (ecto-5'-nucleotidase) in mouse microvessel endothelial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F460654

Regulation of ecto-5'-nucleotidase (CD73) in cultured cortical astrocytes by different inflammatory factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F460654

Mechanism of action of IFN-beta in the treatment of multiple sclerosis: a special reference to CD73 and adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F460654

IFN-beta protects from vascular leakage via up-regulation of CD73.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F460654

Regulation of ecto-5´-nucleotidase by docosahexaenoic acid in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F460654

Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

CD73 expression as a potential marker of good prognosis in breast carcinoma.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121992

Ecto-5′-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells

29 October 2018

1 reference

12 December 2020

[Characteristics and clinical significance of CD73 expression in subtypes of leukemia]

1 reference

12 December 2020

Regulation of endothelial CD73 by adenosine: paracrine pathway for enhanced endothelial barrier function

1 reference

12 December 2020

Activity and expression of ecto-5'-nucleotidase/CD73 are increased by thyroid hormones in vascular smooth muscle cells

1 reference

12 December 2020

CD73 as a novel prognostic biomarker for human colorectal cancer

1 reference

12 December 2020

Opportunities and challenges for anti-CD73 cancer therapy

1 reference

12 December 2020

Identifiers

DOI

10.1155/2014/460654

1 reference

30 July 2017

1 reference

30 July 2017

1 reference